Introduction
In September 2023, a mid-sized pharmaceutical company became the victim of a sophisticated and coordinated cybersecurity attack. The organization was in the spotlight due to its upcoming FDA approval and IPO announcements for a groundbreaking new product, inadvertently drawing the attention of cybercriminals.
This heightened visibility, coupled with insufficient cybersecurity measures, made the company an ideal target.